iSpecimen

iSpecimen Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of iSpecimen (ISPC) as of Nov 5, 2026 is 40.43 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 66.12 % — a change of -38.85% (lower).

Cash Conversion

40.43 %

YoY

-38.85%

Last updated:

Cash Conversion Rate (OCF/Net Income) of iSpecimen is 2025 40.43 % . Cash Conversion Rate (OCF/Net Income) of iSpecimen was 2024 66.12 % . It decreases by -38.85% lower compared to the previous year.

The iSpecimen Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
50.15 USD
Jan 1, 2019
56.69 USD
Jan 1, 2020
6.20 USD
Jan 1, 2021
119.04 USD
Jan 1, 2022
56.78 USD
Jan 1, 2023
52.32 USD
Jan 1, 2024
66.12 USD
Jan 1, 2025
40.43 USD
The iSpecimen Cash Conversion history
YEARCash ConversionYoY
40.43 %-38.85%
66.12 %+26.37%
52.32 %-7.85%
56.78 %-52.30%
119.04 %+1,820.38%
6.20 %-89.07%
56.69 %+13.04%
50.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iSpecimen Stock analysis

What does iSpecimen do? iSpecimen, Inc. generates revenue through its iSpecimen Marketplace platform, which connects healthcare providers with biospecimens to researchers in biopharmaceutical, in vitro diagnostic (IVD), and government/academic sectors. The platform consolidates biospecimen procurement by offering a single online marketplace where healthcare supply partners provide de-identified healthcare data, enabling researchers to search, manage workflows, and access administrative tools. Biopharmaceutical companies, IVD firms, and academic institutions purchase access to the platform’s data and services to accelerate medical discovery and streamline procurement processes. The company’s functional areas—search, workflow, data, and administration and reporting—support these transactions through integrated administrative and compliance management for all users. The iSpecimen Marketplace platform serves biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions by providing a centralized hub for biospecimen procurement. Healthcare providers supplying biospecimens use the platform to list their collections, while researchers from the target sectors access the data for their studies. The platform’s de-identified healthcare data, compiled from healthcare supply partners, is a key asset that drives transactions. Administrative and reporting functions within the platform streamline operations for both suppliers and researchers, reducing manual effort and improving compliance. iSpecimen, Inc. monetizes its platform by facilitating connections between biospecimen suppliers and researchers across biopharmaceutical, IVD, and academic sectors. The company’s revenue comes from transactions and services provided through the iSpecimen Marketplace, which includes search capabilities, workflow management, data access, and administrative support. Healthcare supply partners contribute de-identified healthcare data to the platform, which researchers use to identify and procure necessary biospecimens for medical research and development. iSpecimen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iSpecimen stock

Cash Conversion Rate (OCF/Net Income) of iSpecimen is 40.43 % in 2025.

Cash Conversion Rate (OCF/Net Income) of iSpecimen changed from 66.12 % to 40.43 %, representing a -38.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) iSpecimen since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s iSpecimen with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — iSpecimen

All Key Metrics — iSpecimen